Delayed oseltamivir still benefits children hospitalized with flu

Oseltamivir reduced the risk for ICU admission among children who were hospitalized with influenza, regardless of how long they had symptoms before starting treatment, according to findings published in JAMA Pediatrics. Oseltamivir (Tamiflu, Genentech) is an antiviral medication approved by the FDA for treating influenza in patients aged 2 weeks or older. The AAP and CDC recommend its use even

Raccontata dahealio.com